Moderna Inc (MRNA)
148.80
+1.88 (+1.28%)
USD |
NASDAQ |
Mar 29, 16:00
149.44
+0.64 (+0.43%)
After-Hours: 07:18
Moderna Profit Margin (Quarterly): 28.45% for Dec. 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 28.45% |
| September 30, 2022 | 32.39% |
| June 30, 2022 | 48.12% |
| March 31, 2022 | 61.57% |
| December 31, 2021 | 70.05% |
| September 30, 2021 | 69.02% |
| June 30, 2021 | 65.95% |
| March 31, 2021 | 70.05% |
| December 31, 2020 | -119.2% |
| September 30, 2020 | -1.94K% |
| June 30, 2020 | -403.4% |
| Date | Value |
|---|---|
| March 31, 2020 | -3.10K% |
| December 31, 2019 | -1.17K% |
| September 30, 2019 | -923.8% |
| June 30, 2019 | -1.35K% |
| March 31, 2019 | -939.3% |
| December 31, 2018 | -431.0% |
| September 30, 2018 | -219.1% |
| June 30, 2018 | -350.7% |
| March 31, 2018 | -263.6% |
| December 31, 2017 | -42.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.10K%
Minimum
Mar 2020
70.05%
Maximum
Dec 2021
-538.2%
Average
-241.3%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 20.56% |
| Johnson & Johnson | 14.85% |
| Merck & Co Inc | 21.81% |
| Novavax Inc | -50.99% |
| Amgen Inc | 23.63% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 48.44% |
| Return on Assets | 32.10% |
| Return on Invested Capital | 48.44% |
| Gross Profit Margin (Quarterly) | 62.75% |
| Operating Margin (Quarterly) | 30.69% |
| Return on Net Operating Assets | 120.0% |